Harvard Bioscience Share Price Today
(NASDAQ: HBIO)

Name: Harvard Bioscience Share Price Today (NASDAQ: HBIO) - Harvard Bioscience Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Harvard Bioscience share price is $0.8 & ₹69.58 as on 6 Mar 2025, 2.30 'hrs' IST

$0.8

▲

0.02

(2.4%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Harvard Bioscience share price in Dollar and Rupees. Guide to invest in Harvard Bioscience stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Harvard Bioscience, along with analyst recommendations, forecasts, and comprehensive financials.

Harvard Bioscience share price movements

Today's Low: $0.80
Today's High: $0.84
$0.80
0.62%
Downside
Day's Volatility :5.35%
Upside
4.76%
52 Weeks Low: $0.78
52 Weeks High: $4.70
$0.80
2.25%
Downside
52 Weeks Volatility :83.36%
Upside
82.98%

Harvard Bioscience (HBIO) Returns

Period	Harvard Bioscience Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-62.48%	3.7%	0.0%
6 Months	-70.59%	-2.8%	0.0%
1 Year	-80.46%	2.5%	0.0%
3 Years	-85.13%	12.9%	-11.6%

Harvard Bioscience (HBIO) Key Statistics

in dollars & INR

Previous Close	$0.7841
Open	$0.82
Today's High	$0.84
Today's Low	$0.79505
Market Capitalization	$35.0M
Today's Volume	$438.7K
52 Week High	$4.7
52 Week Low	$0.782
Revenue TTM	$97.7M
EBITDA	$2.9M
Earnings Per Share (EPS)	$-0.33
Profit Margin	-14.57%
Quarterly Earnings Growth YOY	-0.8%
Return On Equity TTM	-20.4%

How to invest in Harvard Bioscience Stock (HBIO) from India?

It is very easy for Indian residents to invest directly in Harvard Bioscience from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Harvard Bioscience stock in both Indian Rupees (INR) and US Dollars (USD). Search for Harvard Bioscience or HBIO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Harvard Bioscience or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Harvard Bioscience shares which would translate to 1.087 fractional shares of Harvard Bioscience as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Harvard Bioscience, in just a few clicks!

Returns in Harvard Bioscience (HBIO) for Indian investors in Rupees

The Harvard Bioscience stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Harvard Bioscience investment value today

Current value as on today

₹24,414

Returns

₹75,586

(-75.59%)

Returns from Harvard Bioscience Stock

₹80,535 (-80.54%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Harvard Bioscience (HBIO)

131%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Harvard Bioscience Stock from India on INDmoney has increased by 131% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Harvard Bioscience

BlackRock Inc
6.84%
Punch & Associates Inv Mgmt Inc
6.32%
Harvey Partners LLC
6.15%
AMH Equity Ltd
5.73%
Vanguard Group Inc
4.95%
Royce & Associates, LP
4.51%

Analyst Recommendation on Harvard Bioscience

Buy

88%Buy

11%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for Harvard Bioscience(by analysts ranked 0 to 5 stars)

Based on 9 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Harvard Bioscience Stock (HBIO)

What analysts predicted

Upside of 681.25%

Target:

$6.25

Current:

$0.80

Insights on Harvard Bioscience Stock (Ticker Symbol: HBIO)

Price Movement
In the last 1 month, HBIO stock has moved down by -45.8%
Decreasing Revenue
Revenue is down for the last 4 quarters, 28.15M → 21.97M (in $), with an average decrease of 7.9% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -2.92M → -4.80M (in $), with an average decrease of 64.1% per quarter
HBIO vs ISRG (1 yr)
In the last 1 year, Intuitive Surgical, Inc. has given 46.3% return, outperforming this stock by 126.8%
HBIO vs ISRG (3 yr)
In the last 3 years, Intuitive Surgical, Inc. has given 87.9% return, outperforming this stock by 173.1%
Price to Sales
ForHBIO every $1 of sales, investors are willing to pay $0.4, whereas for Intuitive Surgical, Inc., the investors are paying $24.2 for every $1 of sales.

HBIO Harvard Bioscience Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$120.8M	↑ 18.54%
Net Income	$-3.5M	↑ 300.23%
Net Profit Margin	-2.87%	↓ 2.02%

	FY19	Y/Y Change
Revenue	$116.2M	↓ 3.81%
Net Income	$-4.7M	↑ 35.38%
Net Profit Margin	-4.03%	↓ 1.16%

	FY20	Y/Y Change
Revenue	$102.1M	↓ 12.12%
Net Income	$-7.8M	↑ 66.63%
Net Profit Margin	-7.65%	↓ 3.62%

	FY21	Y/Y Change
Revenue	$118.9M	↑ 16.46%
Net Income	$-288.0K	↓ 96.31%
Net Profit Margin	-0.24%	↑ 7.41%

	FY22	Y/Y Change
Revenue	$113.3M	↓ 4.68%
Net Income	$-9.5M	↑ 3204.17%
Net Profit Margin	-8.4%	↓ 8.16%

	FY23	Y/Y Change
Revenue	$112.3M	↓ 0.96%
Net Income	$-3.4M	↓ 64.11%
Net Profit Margin	-3.04%	↑ 5.36%

	Q2 FY23	Q/Q Change
Revenue	$28.8M	↓ 4.06%
Net Income	$-980.0K	↓ 257.56%
Net Profit Margin	-3.41%	↓ 5.49%

	Q3 FY23	Q/Q Change
Revenue	$25.4M	↓ 11.81%
Net Income	$-1.2M	↑ 26.43%
Net Profit Margin	-4.89%	↓ 1.48%

	Q4 FY23	Q/Q Change
Revenue	$28.2M	↑ 11.0%
Net Income	$-1.8M	↑ 46.73%
Net Profit Margin	-6.46%	↓ 1.57%

	Q1 FY24	Q/Q Change
Revenue	$24.5M	↓ 12.93%
Net Income	$-4.7M	↑ 158.2%
Net Profit Margin	-19.15%	↓ 12.69%

	Q2 FY24	Q/Q Change
Revenue	$23.1M	↓ 5.77%
Net Income	$-2.9M	↓ 37.64%
Net Profit Margin	-12.67%	↑ 6.48%

	Q3 FY24	Q/Q Change
Revenue	$22.0M	↓ 4.88%
Net Income	$-4.8M	↑ 64.06%
Net Profit Margin	-21.86%	↓ 9.19%

	FY18	Y/Y Change
Profit	$63.2M	↑ 32.74%

	FY19	Y/Y Change
Profit	$64.3M	↑ 1.81%

	FY20	Y/Y Change
Profit	$58.0M	↓ 9.76%

	FY21	Y/Y Change
Profit	$67.7M	↑ 16.56%

	FY22	Y/Y Change
Profit	$60.8M	↓ 10.1%

	FY23	Y/Y Change
Profit	$66.1M	↑ 8.64%

	Q2 FY23	Q/Q Change
Profit	$16.7M	↓ 9.12%

	Q3 FY23	Q/Q Change
Profit	$14.7M	↓ 11.67%

	Q4 FY23	Q/Q Change
Profit	$14.9M	↑ 1.43%

	Q1 FY24	Q/Q Change
Profit	$13.4M	↓ 10.03%

	Q2 FY24	Q/Q Change
Profit	$11.9M	↓ 11.55%

	Q3 FY24	Q/Q Change
Profit	$12.8M	↑ 7.39%

	FY18	Y/Y Change
Operating Cash Flow	$2.3M	↑ 121.76%
Investing Cash Flow	$-53.8M	↑ 5766.52%
Financing Cash Flow	$53.1M	↓ 3060.55%

	FY19	Y/Y Change
Operating Cash Flow	$8.0M	↑ 243.3%
Investing Cash Flow	$-229.0K	↓ 99.57%
Financing Cash Flow	$-7.6M	↓ 114.37%

	FY20	Y/Y Change
Operating Cash Flow	$9.3M	↑ 15.96%
Investing Cash Flow	$-1.4M	↑ 512.23%
Financing Cash Flow	$-8.0M	↑ 4.47%

	FY21	Y/Y Change
Operating Cash Flow	$1.3M	↓ 86.48%
Investing Cash Flow	$-1.3M	↓ 4.07%
Financing Cash Flow	$-252.0K	↓ 96.84%

	FY22	Y/Y Change
Operating Cash Flow	$1.2M	↓ 8.72%
Investing Cash Flow	$-1.6M	↑ 18.22%
Financing Cash Flow	$-2.8M	↑ 1025.79%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$3.6M	↑ 96.03%
Investing Cash Flow	$-625.0K	↓ 317.01%
Financing Cash Flow	$-2.4M	↓ 17.91%

Harvard Bioscience Technicals Summary

Sell

Neutral

Buy

Harvard Bioscience is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Harvard Bioscience (HBIO) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Harvard Bioscience Inc	-51.92%	-70.59%	-80.46%	-85.13%	-69.47%
Intuitive Surgical, Inc.	-2.01%	19.16%	46.34%	94.07%	233.7%
Alcon Ag	3.44%	0.33%	10.46%	30.15%	67.23%
Resmed Inc.	-6.92%	-8.56%	21.46%	-9.48%	44.87%
Becton, Dickinson And Company	-7.55%	-3.91%	-4.87%	-18.81%	-2.89%
Cooper Companies Inc., The	-4.17%	-14.24%	-10.35%	-8.95%	15.06%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Harvard Bioscience Inc	NA	NA	2.89	0.05	-0.2	-0.02	NA	1.5
Intuitive Surgical, Inc.	88.57	88.57	3.92	8.06	0.16	0.09	NA	46.08
Alcon Ag	45.84	45.84	2.88	3.26	0.05	0.03	0.0	43.58
Resmed Inc.	27.56	27.56	1.52	9.47	0.26	0.14	0.01	35.77
Becton, Dickinson And Company	38.47	38.47	1.04	14.42	0.07	0.04	0.02	87.78
Cooper Companies Inc., The	46.74	46.74	9.59	3.98	0.05	0.04	NA	40.5

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Harvard Bioscience Inc	Buy	$35.0M	-69.47%	NA	-14.57%
Intuitive Surgical, Inc.	Buy	$199.0B	233.7%	88.57	27.81%
Alcon Ag	Buy	$45.8B	67.23%	45.84	10.27%
Resmed Inc.	Buy	$34.0B	44.87%	27.56	25.35%
Becton, Dickinson And Company	Buy	$64.4B	-2.89%	38.47	8.37%
Cooper Companies Inc., The	Buy	$18.1B	15.06%	46.74	10.07%

About Harvard Bioscience

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It also provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through sales organizations, websites, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic labs. It primarily sells its products under Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.

Organization	Harvard Bioscience
Employees	391
CEO	Mr. James W. Green
Industry	Health Technology

Management People of Harvard Bioscience

Name	Title
Mr. James W. Green	President, CEO & Chairman
Ms. Jennifer Cote CPA, CGMA	CFO & Treasurer
Mr. John J. Fry J.D.	Chief Legal Counsel & Corporation Secretary
Mr. Ryan Wallace	Senior Vice President of Global Sales
Ms. Lori Packer	Vice President of Global People Operations
Kathryn Flynn	Corporate Controller
David Sirois	Director of Corporate Accounting & SEC Reporting

Important FAQs about investing in HBIO Stock from India :

What is Harvard Bioscience share price today?

Harvard Bioscience share price today stands at $0.80, Open: $0.82 ; Previous Close: $0.78 ; High: $0.84 ; Low: $0.80 ; 52 Week High: $4.70 ; 52 Week Low: $0.78.

The stock opens at $0.82, after a previous close of $0.78. The stock reached a daily high of $0.84 and a low of $0.80, with a 52-week high of $4.70 and a 52-week low of $0.78.

Can Indians buy Harvard Bioscience shares?

Yes, Indians can invest in the Harvard Bioscience (HBIO) from India.

With INDmoney, you can buy Harvard Bioscience at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Harvard Bioscience at zero transaction cost.

How can I buy Harvard Bioscience shares from India?

It is very easy to buy Harvard Bioscience from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Harvard Bioscience (HBIO) be purchased?

Yes, you can buy fractional shares of Harvard Bioscience with INDmoney app.

What are the documents required to start investing in Harvard Bioscience stocks?

To start investing in Harvard Bioscience, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.